Eli Casdin is of STANDARD BIOTOOLS INC.. Currently has a direct ownership of 2.75 Million shares of LAB, which is worth approximately $5.5 Million. The most recent transaction as insider was on Jul 19, 2024, when has been sold 1,588 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.75M
0% 3M change
3663.0% 12M change
Total Value Held $5.5 Million

Eli Casdin Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 19 2024
BUY
Grant, award, or other acquisition
-
1,588 Added 0.06%
2,752,332 Common Stock
Jun 28 2024
BUY
Grant, award, or other acquisition
-
43,128 Added 1.54%
2,750,744 Common Stock
Feb 20 2024
BUY
Grant, award, or other acquisition
$57,000 $2.5 p/Share
22,800 Added 18.04%
103,556 Common Stock
Jan 05 2024
BUY
Grant, award, or other acquisition
-
7,614 Added 8.62%
80,756 Common Stock
Jun 14 2023
BUY
Grant, award, or other acquisition
-
26,376 Added 26.5%
73,142 Common Stock
Jun 15 2022
BUY
Grant, award, or other acquisition
-
30,914 Added 39.8%
46,766 Common Stock
Apr 04 2022
BUY
Grant, award, or other acquisition
-
15,852 Added 50.0%
15,852 Common Stock

Also insider at

IPSC
Century Therapeutics, Inc. Healthcare
SMFR
Sema4 Holdings Corp. Healthcare
ABSI
Absci Corp Healthcare
TNYA
Tenaya Therapeutics, Inc. Healthcare
SLGC
SomaLogic, Inc. Healthcare
EQRX
EQRx, Inc. Healthcare
EC

Eli Casdin

New York, NY

Track Institutional and Insider Activities on LAB

Follow STANDARD BIOTOOLS INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LAB shares.

Notify only if

Insider Trading

Get notified when an Standard Biotools Inc. insider buys or sells LAB shares.

Notify only if

News

Receive news related to STANDARD BIOTOOLS INC.

Track Activities on LAB